The 13th International AIDS Society Conference on HIV Science (IAS 2025) is taking place in Kigali, Rwanda, and virtually, ...

In 2019, South Africa adopted dolutegravir / lamivudine / tenofovir (TLD) as its preferred first-line regimen, replacing a regimen known as TEE or tenofovir / emtricitabine / efavirenz for most adults ...

BHIVA recommends that people aged 40 and over should be offered a statin irrespective of lipid levels or estimated cardiovascular risk. People with HIV aged 40 and over with an estimated 10-year risk ...

These goals have not been achieved: by the end of 2020, 928,750 people had started taking PrEP worldwide: just under half of all sex workers and approximately a third of MSM, people who inject drugs ...

Professor Yvonne Bryson of the University of California Los Angeles described the new case at the conference and an accompanying press briefing. The middle-aged (post-menopausal) woman, a participant ...

Over half of funding for anti-gender actors in Europe appears to come from within Europe itself, with significant amounts of money also flowing from the US and the Russian Federation, according to ...

It’s rare in any branch of medicine that a trial of a new drug can report 100% efficacy, and a first in HIV science. But that’s what happened on Friday, when Gilead Sciences announced that no HIV ...

Doxycycline post-exposure prophylaxis (doxyPEP), which was found to be highly effective at preventing sexually transmitted infections (STIs) among gay men and transgender women, did not protect young ...

Advocates from around the world came together at the U=U Global Summit at the 24th International AIDS Conference (AIDS 2022) in Montreal last month to share successes and challenges that continue to ...

📢 With heavy hearts, we announce the proposed closure of our beloved charity, NAM aidsmap, this month. After 37 years of pioneering health journalism, community engagement, and empowerment through ...

But injectable HIV treatment could have a future in the global south, particularly when other long-acting products are developed, experts said at the 12th International AIDS Society Conference on HIV ...